A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page
U.S. News & World Report's 2012 "Best Hospitals"

Bone and Soft Tissue Oncology Program

 

Ask the Expert

Dr. Henock Wolde-Semait’s Bio Image

Get answers to your Orthopaedic Oncology questions.

Dr. Henock Wolde-Semait’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Related Content


 

The Bone and Soft Tissue Oncology Program consists of a group of specialists experienced in the treatment of:

Working with referring physicians to provide patients with the best possible care, we treat all types of musculoskeletal and soft tissue malignancies. We specialize in limb-sparing surgery, treatment of metastatic disease, and second opinions.

Surgery is the mainstay of treatment for all soft tissue sarcomas, and the University of Maryland Marlene and Stewart Greenebaum Cancer Center provides surgical expertise in the treatment of extremity, abdominal and retroperitoneal sarcomas. Surgical oncologists also work with our Department of Diagnostic Radiology to make diagnoses and formulate treatment plans. This strategy is extremely valuable, especially for limb-salvaging treatments.

We also participate in clinical trials in conjunction with Radiation Therapy Oncology Group (RTOG), a nationwide clincial trials group, and the American College of Surgeons Oncology Group.

Patients in the program are evaluated in the multidisciplinary clinic by a team of: surgical oncologists, medical oncologists, radiation oncologists, radiologists, orthopedic surgeons, nurses, and rehabilitation specialists.

What's Inside
This page was last updated on: December 18, 2012.